Robert M, Burgel J S, Serre I, Guiter J, Grasset D
Service d'Urologie I, Hôpital Lapeyronie, Montpellier, France.
Prog Urol. 1996 Aug-Sep;6(4):558-63.
To evaluate the frequency, predictive parameters and prognosis of urethral recurrence after cystoprostatectomy for urothelial bladder cancer.
From 1989 to 1994, 8 of a series of 185 patients (4.3%) treated by cystoprostatectomy for bladder carcinoma between 1988 and 1993 developed urethral recurrence revealed by urethral bleeding, with a follow-up of 6 to 36 months (m = 16).
The initial bladder tumour was localized in 3 cases and multifocal in 5 cases. The posterior urethra was not involved in 5 cases, but presented lesions of CIS in 1 case and neoplastic infiltration also involving the prostate in 2 cases. These recurrences were treated by urethrectomy, as first-line treatment in 7 cases and after failure of endoscopic treatment in 1 case. A balanic recurrence required distal penectomy following insufficient urethral resection. The course was very rapidly unfavourable for 3 patients with generalized cancer and an intercurrent disease was fatal in 1 other case. With a follow-up of 12 to 44 months (m = 26), 4 patients are alive with no obvious signs of disease progression.
The indications for prophylactic urethrectomy can be reserved to patients with positive urethral resection margins, provided all other cases are submitted to strict surveillance. In the context of a replacement bladder, it is essential to exclude neoplastic involvement of the posterior urethra or prostate, especially in patients previously treated by intravesical instillations.
评估膀胱尿路上皮癌行膀胱前列腺切除术后尿道复发的频率、预测参数及预后。
1989年至1994年,在1988年至1993年间接受膀胱前列腺切除术治疗膀胱癌的185例患者中,有8例(4.3%)出现尿道出血,经随访6至36个月(平均16个月)发现尿道复发。
最初的膀胱肿瘤3例为局限性,5例为多灶性。5例后尿道未受累,1例出现原位癌病变,2例肿瘤浸润累及前列腺。这些复发患者均接受了尿道切除术,7例作为一线治疗,1例在内镜治疗失败后进行。阴茎头复发在尿道切除不充分后需行阴茎远端切除术。3例广泛转移癌患者病情进展迅速,另1例因并发疾病死亡。随访12至44个月(平均26个月),4例患者存活,无明显疾病进展迹象。
预防性尿道切除术的适应证可仅限于尿道切缘阳性的患者,前提是其他所有病例均接受严格监测。在膀胱替代的情况下,必须排除后尿道或前列腺的肿瘤累及,尤其是既往接受过膀胱内灌注治疗的患者。